GSK

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: JNJ PFE MRK BMY LLY NVS AZN ABBV SNY GILD

| Held by: FVD AVDE PPH FENI RODM DFAX AVIV BINV PLDR FFLC

Index	-	P/E	18.84	EPS (ttm)	2.15	Insider Own	0.00%	Shs Outstand	2.02B	Perf Week	0.96%
Market Cap	81.46B	Forward P/E	8.33	EPS next Y	4.85	Insider Trans	-	Shs Float	2.01B	Perf Month	3.07%
Enterprise Value	99.68B	PEG	2.02	EPS next Q	1.24	Inst Own	19.09%	Short Float	0.55%	Perf Quarter	-1.04%
Income	4.43B	P/S	1.99	EPS this Y	10.23%	Inst Trans	-1.53%	Short Ratio	2.29	Perf Half Y	2.39%
Sales	40.95B	P/B	4.04	EPS next Y	10.42%	ROA	5.73%	Short Interest	11.14M	Perf YTD	19.56%
Book/sh	10.02	P/C	16.43	EPS next 5Y	9.34%	ROE	23.04%	52W High	43.62 -7.30%	Perf Year	-7.62%
Cash/sh	2.46	P/FCF	10.53	EPS past 3/5Y	-24.61% -11.63%	ROIC	10.74%	52W Low	31.72 27.49%	Perf 3Y	28.32%
Dividend Est.	1.75 (4.32%)	EV/EBITDA	8.35	Sales past 3/5Y	5.68% -1.42%	Gross Margin	71.69%	Volatility	1.59% 1.45%	Perf 5Y	1.92%
Dividend TTM	1.64 (4.06%)	EV/Sales	2.43	EPS Y/Y TTM	-13.29%	Oper. Margin	17.18%	ATR (14)	0.75	Perf 10Y	1.51%
Dividend Ex-Date	Aug 15, 2025	Quick Ratio	0.57	Sales Y/Y TTM	3.46%	Profit Margin	10.81%	RSI (14)	55.72	Recom	3.00
Dividend Gr. 3/5Y	-16.94% -9.13%	Current Ratio	0.87	EPS Q/Q	30.61%	SMA20	1.08%	Beta	0.52	Target Price	43.70
Payout	94.89%	Debt/Eq	1.17	Sales Q/Q	7.23%	SMA50	4.33%	Rel Volume	0.50	Prev Close	40.83
Employees	68629	LT Debt/Eq	1.03	Earnings	Jul 30 BMO	SMA200	8.19%	Avg Volume	4.86M	Price	40.44
IPO	Mar 28, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.58% 1.12%	Trades		Volume	1,977,287	Change	-0.97%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-25	Downgrade	Berenberg	Buy → Hold
Apr-15-25	Initiated	Exane BNP Paribas	Neutral	$35.25
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Nov-15-24	Downgrade	Deutsche Bank	Buy → Hold
Nov-12-24	Downgrade	Jefferies	Buy → Hold	$53 → $39.50
Oct-31-24	Downgrade	Guggenheim	Buy → Neutral
Jul-08-24	Downgrade	UBS	Buy → Neutral
May-30-24	Initiated	Goldman	Neutral	$47
Mar-04-24	Upgrade	Guggenheim	Neutral → Buy
Feb-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$44
Jan-16-24	Resumed	UBS	Buy
Jan-03-24	Upgrade	Jefferies	Hold → Buy	$48
Jul-14-23	Initiated	HSBC Securities	Reduce
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight
Dec-05-22	Downgrade	BofA Securities	Neutral → Underperform
Nov-11-22	Downgrade	UBS	Neutral → Sell
Sep-15-22	Upgrade	Credit Suisse	Underperform → Neutral

Show Previous Ratings

Sep-12-25 08:14PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Sep-11-25 12:49PM	Kepler Capital Maintains a Hold Rating on GSK plc (GSK) (Insider Monkey)
11:30AM	Why Is Editas (EDIT) Down 16.9% Since Last Earnings Report? (Zacks)
Sep-06-25 12:58AM	TD Cowen Maintains a Hold Rating on GSK plc (GSK), Sets a PT of $45 (Insider Monkey)
Sep-03-25 11:30AM	BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound? (Zacks)
10:47AM	Loading…
10:47AM	IONS Hits 52-Week High on Tryngolza's Success in Lowering Triglyceride (Zacks)
Sep-02-25 05:33PM	Top Analyst Reports for NVIDIA, Chevron & Booking (Zacks)
09:48AM	GSK Adds Around $5B in a Month: Here's How to Play the Stock (Zacks)
Aug-26-25 09:40AM	GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU (Zacks)
Aug-22-25 11:11AM	BMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now? (Zacks)
Aug-21-25 09:49AM	JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug (Zacks)
Aug-18-25 09:25AM	GILD Stock Up 7% Post Q2 Earnings: Should You Buy Now or Wait? (Zacks)
Aug-13-25 12:31PM	Theravance's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y (Zacks)
Aug-11-25 04:19AM	GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic (Investing.com)
Aug-08-25 09:23AM	GILD Stock Rises on Q2 Earnings and Sales Beat, '25 View Up (Zacks)
03:31AM	Loading…
03:31AM	GSK to Receive $370 Million in U.S. Patent Litigation Settlement (The Wall Street Journal)
Aug-04-25 07:58AM	GILD Likely to Beat on Q2 Earnings: Buy, Sell or Hold the Stock? (Zacks)
Aug-01-25 07:46AM	Stocks Buckle Under Trump Tariffs; Amazon Slumps: Markets Wrap (Bloomberg)
07:21AM	Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices (The Wall Street Journal)
05:57AM	Stock Market Today: Stocks Fall on Trump's Tariff Blitz; Jobs Report Due (The Wall Street Journal)
Jul-31-25 04:16PM	What Trump's Big Pharma CEO letters mean for drug pricing power (Yahoo Finance Video)
09:22AM	Company News for Jul 31, 2025 (Zacks)
Jul-30-25 05:48PM	Analyst Report: GSK plc (Morningstar Research)
11:57AM	GSK CEO: Innovation is the secret to bringing down cost of overall healthcare (CNBC TV)
11:42AM	GSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise (Zacks)
09:21AM	GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth (Benzinga)
07:05AM	GSK (GSK) Q2 Earnings and Revenues Beat Estimates (Zacks)
02:49AM	GSK Upbeat on Guidance After Specialty Medicines Boost Sales (The Wall Street Journal)
Jul-27-25 09:53PM	Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology (PR Newswire)
Jul-24-25 02:59PM	Europes Pharma Stocks Look Cheap but Tariffs Cloud the Outlook (Barrons.com)
10:00AM	Loading…
10:00AM	Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for (Zacks)
09:00AM	GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults (Business Wire)
Jul-23-25 10:00AM	GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-21-25 09:38AM	Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect (Zacks)
Jul-19-25 11:12AM	Warren Buffett says this book changed his life forever. Here's the real key to long-term gains (Moneywise)
Jul-18-25 09:32PM	Stock Market News, July 18, 2025: Another Record for Nasdaq (The Wall Street Journal)
02:47PM	BofA Maintains a Sell Rating on GSK plc (GSK), Sets a PT of p1,510 (Insider Monkey)
01:23PM	Global Stocks Recap: Alibaba, Saab, Burberry, GSK (The Wall Street Journal)
10:39AM	FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo (Zacks)
09:30AM	Global Stocks in the Spotlight: Alibaba, Saab, Burberry, GSK (The Wall Street Journal)
08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
07:39AM	Stocks to Watch Friday: Chevron, Hess, Netflix, 3M (The Wall Street Journal)
07:32AM	GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning (Benzinga)
Jul-17-25 06:19PM	FDA Committee Votes Against GSK Blood Cancer Drug Blenrep (The Wall Street Journal)
02:37PM	GSK stock falls after FDA panel rejects blood cancer drug Blenrep (Investing.com)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
07:00AM	US FDA Approves GSKs SHINGRIX in a Prefilled Syringe Presentation (Business Wire)
Jul-15-25 12:54PM	Merck Starts Phase III Studies on Once-Monthly Pill for HIV Prevention (Zacks)
Jul-14-25 10:12AM	FDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger Adults (Zacks)
Jul-12-25 09:36AM	FDA willing to trade faster drug reviews for lower prices, Bloomberg reports (TipRanks)
Jul-10-25 09:13AM	GSK begins shipping influenza vaccine doses for the 2025-26 flu season (Business Wire)
Jul-09-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
09:19AM	GSK's Specialty Medicines Unit on a Strong Footing: Here's Why (Zacks)
Jul-08-25 09:51AM	Gilead Sciences Rallies 27.2% in Six Months: Buy or Sell the Stock? (Zacks)
09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
Jul-04-25 09:00AM	How Much of Your Portfolio Should Be in International Stocks? (The Wall Street Journal)
Jul-03-25 12:10PM	Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:36AM	Robert F. Kennedy Jr. Just Did The Unexpected. He Helped Moderna. (Investor's Business Daily)
09:06AM	MRNA Stock Jumps on CDC's Revised RSV Vaccine Recommendations (Zacks)
Jul-02-25 04:33PM	Kennedy Expands RSV Vaccine Recommendations. Moderna, Pfizer Shares Are Up. (Barrons.com)
09:10AM	Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jul-01-25 09:33AM	Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock? (Zacks)
09:17AM	Moderna Stock Gains on Encouraging Flu Vaccine Data (Zacks)
Jun-27-25 04:25PM	Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care (Investor's Business Daily)
11:11AM	Gilead Rises After Supreme Court Says Insurers Must Cover HIV Prevention Drugs (Investor's Business Daily)
10:17AM	Why This Looming Supreme Court Decision Could Rattle Gilead Sciences (Investor's Business Daily)
Jun-26-25 02:28PM	The Anti-Vax Movement Solidifies Control of the CDCs Vaccine Committee (Barrons.com)
Jun-24-25 12:15PM	EMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related Itch (Zacks)
09:00AM	FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis (Business Wire)
Jun-23-25 09:53AM	FDA Extends INCY's Application for Opzelura Label Expansion (Zacks)
09:40AM	GSK (GSK) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Jun-19-25 01:30PM	FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention (Zacks)
Jun-18-25 08:57PM	Analyst Report: GSK plc (Morningstar Research)
10:22AM	GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold? (Zacks)
10:00AM	Trump administration weighs crackdown on pharma ads, Bloomberg says (TipRanks)
Jun-17-25 09:50AM	Here's Why GSK (GSK) is a Strong Momentum Stock (Zacks)
08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
Jun-16-25 11:20AM	EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy (Zacks)
09:40AM	Is FrancoNevada (FNV) Stock Outpacing Its Basic Materials Peers This Year? (Zacks)
09:40AM	Is Central Japan Railway Co. (CJPRY) Stock Outpacing Its Transportation Peers This Year? (Zacks)
09:40AM	Is EPR Properties (EPR) Stock Outpacing Its Finance Peers This Year? (Zacks)
09:40AM	Is Adyen (ADYEY) Stock Outpacing Its Computer and Technology Peers This Year? (Zacks)
09:40AM	Are Consumer Discretionary Stocks Lagging Accel Entertainment (ACEL) This Year? (Zacks)
09:40AM	Are Construction Stocks Lagging EMCOR Group (EME) This Year? (Zacks)
09:40AM	Is AppLovin (APP) Stock Outpacing Its Business Services Peers This Year? (Zacks)
09:40AM	Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? (Zacks)
09:33AM	GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US (Business Wire)
Jun-13-25 12:45PM	Senators to propose ban on drug ads to consumers, WSJ reports (TipRanks)
Jun-12-25 08:45PM	Analyst Report: GSK plc (Morningstar Research)
Jun-11-25 10:20AM	Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel (TipRanks)
09:47AM	FDA Places Clinical Hold on Gilead's HIV Studies, Stock Down (Zacks)
Jun-10-25 04:10PM	Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee (Investor's Business Daily)
09:10AM	3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income (Zacks)
Jun-09-25 06:07PM	Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr. (Investor's Business Daily)
Jun-07-25 05:59AM	Patents and economies of scale support Pfizer's wide moat (GuruFocus.com)
Jun-06-25 09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
Jun-05-25 11:31AM	Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue? (Zacks)
Jun-03-25 11:53AM	TBPH to Sell Remaining Trelegy Royalty Interest to GSK, Stock Rises (Zacks)
11:41AM	FDA Accepts GSK's NDA for Linerixibat in Rare Disease-Related Itch (Zacks)

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GSK plc	10% Owner	Sep 27 '24	Buy	8.00	2,791,930	22,335,440	16,775,691	Oct 01 05:54 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GSK Plc ADR

Upgrade your FINVIZ experience